EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Atypical Diabetes: What Have We Learned and What Does the Future Hold?

Stephen I Stone iD, Ashok Balasubramanyam iD, Jennifer E Posey

Diabetes Care · 01.05.2024 · 47 (5) · 770-781

DOI: 10.2337/dci23-0038 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes Care, online erschienen am 08.02.2024. Verfasst von Stephen I Stone und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Insulin Resistance. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NIH Rare and Atypical Diabetes Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As our understanding of the pathophysiology of diabetes evolves, we increasingly recognize that many patients may have a form of diabetes that does not neatly fit with a diagnosis of either type 1 or type 2 diabetes. The discovery and description of these forms of “atypical diabetes” have led to major contributions to our collective understanding of the basic biology that drives insulin secretion, insulin resistance, and islet autoimmunity. These discoveries now pave the way to a better classification of diabetes based on distinct endotypes. In this review, we highlight the key biological and clinical insights that can be gained from studying known forms of atypical diabetes. Additionally, we provide a framework for identification of patients with atypical diabetes based on their clinical, metabolic, and molecular features. Helpful clinical and genetic resources for evaluating patients suspected of having atypical diabetes are provided. Therefore, appreciating the various endotypes associated with atypical diabetes will enhance diagnostic accuracy and facilitate targeted treatment decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Insulin ResistanceHumansAutoimmunityInsulin Secretion

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
  • Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX.
  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.

ORCID-Profile: Stephen I Stone, Ashok Balasubramanyam

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • NIH Rare and Atypical Diabetes Network
  • NIH

Zitieren

APA

Stone, S. I., Balasubramanyam, A., & Posey, J. E. (2024). Atypical Diabetes: What Have We Learned and What Does the Future Hold?. Diabetes Care, 47(5), 770-781. https://doi.org/10.2337/dci23-0038

Vancouver

Stone SI, Balasubramanyam A, Posey JE. Atypical Diabetes: What Have We Learned and What Does the Future Hold?. Diabetes Care. 2024;47(5):770-781. doi:10.2337/dci23-0038

BibTeX
@article{Stone2024,
  author = {Stone, Stephen I and Balasubramanyam, Ashok and Posey, Jennifer E},
  title = {Atypical Diabetes: What Have We Learned and What Does the Future Hold?},
  journal = {Diabetes Care},
  year = {2024},
  volume = {47},
  number = {5},
  pages = {770--781},
  doi = {10.2337/dci23-0038}
}
Kostenlos starten →